![Per Richard Torbjörn Hallberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 4 M $ au 31/05/2026
Per Richard Torbjörn Hallberg is currently a Director at Takeda Oy, Dova Pharmaceuticals, Inc., Swedish Orphan Biovitrum, Inc., Swedish Orphan Biovitrum (Belgium) SARL, and General Counsel & Head-Legal Affairs at Swedish Orphan Biovitrum AB. Previously, he worked as a Senior Associate at Advokatfirman Lindahl KB, Corporate Counsel at Ferring Pharmaceuticals, Inc., Corporate Counsel at Nycomed AB, and Vice President & General Counsel-Emerging Markets at Takeda AB. He obtained a graduate degree from the University of Lund.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/06/2026 | 78 949 ( 0,02 % ) | 4 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Conseiller Juridique Général | 01/01/2018 |
| DOVA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 12/11/2019 |
Takeda Oy
 Takeda Oy Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | 01/05/2016 |
Swedish Orphan Biovitrum, Inc.
 Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Directeur/Membre du Conseil | - |
Swedish Orphan Biovitrum (Belgium) SARL
 Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Engages in development of treatment for diseases | Directeur/Membre du Conseil | 01/06/2021 |
| Sociétés | Poste | Fin |
|---|---|---|
Takeda AB | Directeur/Membre du Conseil | 01/01/2017 |
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | Conseiller Juridique Général | 01/01/2010 |
Ferring Pharmaceuticals, Inc.
 Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Conseiller Juridique Général | 01/01/2004 |
Advokatfirman Lindahl KB
 Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/01/2001 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Advokatfirman Lindahl KB
Advokatfirman Lindahl KB Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Takeda Oy
Takeda Oy Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets fertility and endocrinology products | Health Technology |
University of Lund
 University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Takeda AB | |
Swedish Orphan Biovitrum, Inc.
Swedish Orphan Biovitrum, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Swedish Orphan Biovitrum (Belgium) SARL
Swedish Orphan Biovitrum (Belgium) SARL BiotechnologyHealth Technology Engages in development of treatment for diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
